BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Innovent's Arcotatug Tavatecan Meets Phase 3 Endpoint in Advanced Gastric Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

June 05, 2026 | News

DHCG And Altruist Biologics Partner To Accelerate Global Biologics Development Through China Manufacturing Expertise

Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational biotherapeutics consulting, and Altruist...

June 05, 2026 | News

NOVI Health and Novo Nordisk Partner to Expand Access to Structured Medical Weight Care in Singapore

The collaboration aims to improve access to lifestyle coaching supported, clinically guided programs for patients exploring medical weight care. NOVI Heal...

June 04, 2026 | News

Travere Secures Global Rights to Civorebrutinib in $1.14 Billion Kidney Disease Partnership with Everest Medicines

Civorebrutinib is an investigational oral, covalent reversible BTK inhibitor designed to provide differentiated efficacy, safety and convenience in immun...

June 04, 2026 | News

Waters Introduces Cyclic IMS P20 to Advance Structural and Spatial Omics Research

Waters Corporation has introduced the Cyclic IMS P20 Mass Spectrometer, a next generation structural and spatial omics platform designed to provide researc...

June 04, 2026 | News

Samsung Epis Holdings Establishes First Global R&D Hub in Beijing to Advance ADC and Novel Drug Development

Establishes its first global research base as part of strategic new business expansion under the holding company structure Ÿ B...

June 03, 2026 | News

Scientific Infrastructure or Expensive Theatre? AI Discovery’s Reckoning in Asia

In October 2025, Eli Lilly announced it would build the most powerful supercomputer ever owned by a drug company. By February 2026, “LillyPod” ...

June 02, 2026 | Analysis

XtalPi Earns Second Milestone Payment As AI Drug Discovery Alliance With DoveTree Gains Momentum

XtalPi (2228.HK), an AI- and robotics- powered drug discovery platform, announced that its strategic collaboration with innovative biopharmaceutical c...

June 02, 2026 | News

Lilly Secures Global Rights To Hanmi's Sonefpeglutide In Potential $1.26 Billion Deal

Lilly licenses Hanmi's sonefpeglutide (LAPSGLP-2 analog) for multiple indications Hanmi Pharm. Co., Ltd. ("Hanmi") announced that they have entered i...

June 02, 2026 | News

China Developed Anaesthetic Cipepofol Secures US FDA Approval, Marking Global Breakthrough

Cipepofol (CYPSEDO) Injection (hereinafter "Cipepofol"), a Class 1 innovative intravenous anesthetic independently developed by Haisco Pharmaceutical ...

June 02, 2026 | News

Syncell Launches Global Discovery Services To Accelerate Biomarker And Drug Target Identification

Global program expands access to unbiased nanoscopic proteomic technology to accelerate biomarker identification and drug target discovery -Syncel...

June 01, 2026 | News

Dizal Secures Priority Review In China For ZEGFROVY In First Line EGFR Exon20ins NSCLC

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of oncology and hematological diseases, announced...

May 29, 2026 | News

Metabolon Launches Verus Metabolomics Profiling Kit To Expand Global Access To In House Metabolomics

Democratizing metabolomics for researchers worldwide, the new kit brings Metabolon's analytically rigorous, scalable metabolomics into workflows designed f...

May 29, 2026 | News

Antengene Receives CDE Endorsement For Pivotal Phase III Study Of CLDN18.2 ADC In Gastric Cancer

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, d...

May 29, 2026 | News

Stay Connected